| PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. | |
| | |
MedLine Citation:
|
PMID: 14736838 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PET/CT is a new imaging technology that has already found a number of clinical applications in oncologic imaging. Widespread introduction into clinical practice started approximately 2.5 years ago. Consequently, the available data are largely preliminary. Nevertheless, it can already be stated that the synthesis of structural and metabolic information improves the accuracy of primary staging and the detection of recurrent disease and has the realistic potential to change patient management in 10 to 20% of cases. PET/CT fusion images can directly guide biopsies or surgical interventions. This article summarizes preliminary data of PET/CT studies and highlights potential clinical applications for PET/CT, with particular emphasis on lymphoma, melanoma and gastrointestinal tumors. |
| | |
Authors:
|
Heiko Schöder; Steven M Larson; Henry W D Yeung |
Related Documents
:
|
10857158 - Sensitivity and specificity of positron emission tomography (pet) for the diagnosis of ... 19949988 - Performance of integrated fdg-pet/contrast-enhanced ct in the diagnosis of recurrent pa... 12409108 - Special interest radiology improves the perceived preoperative stage of gastric cancer. 7753998 - Malignant melanoma: staging with whole-body positron emission tomography and 2-[f-18]-f... 2335598 - Gd-dtpa enhanced mr imaging of the breast in patients with postoperative scarring and s... 6709928 - Respiratory gating in magnetic resonance imaging at 0.5 tesla. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Journal of nuclear medicine : official publication, Society of Nuclear Medicine Volume: 45 Suppl 1 ISSN: 0161-5505 ISO Abbreviation: J. Nucl. Med. Publication Date: 2004 Jan |
Date Detail:
|
Created Date: 2004-01-22 Completed Date: 2004-04-06 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 0217410 Medline TA: J Nucl Med Country: United States |
Other Details:
|
Languages: eng Pagination: 72S-81S Citation Subset: IM |
Affiliation:
|
Department of Radiology, Nuclear Medicine Service, and Gerschel PET Center, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. schoders@mskcc.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Fluorodeoxyglucose F18
/
diagnostic use* Gastrointestinal Neoplasms / diagnosis*, pathology, radiography, radionuclide imaging Humans Image Enhancement / methods* Image Interpretation, Computer-Assisted / methods Lymphoma / diagnosis*, pathology, radiography, radionuclide imaging Melanoma / diagnosis, pathology, radiography, radionuclide imaging Neoplasm Recurrence, Local / diagnosis, pathology, radiography, radionuclide imaging Neoplasm Staging / methods Patient Care Management / methods Radiopharmaceuticals / diagnostic use Subtraction Technique* Systems Integration Tomography, Emission-Computed / methods* Tomography, X-Ray Computed / methods* |
| Chemical | |
Reg. No./Substance:
|
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Why most PET of lung and head-and-neck cancer will be PET/CT.
Next Document: Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT.